| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.218 | 58.040 | 60.942 | 59.094 | 62.436 | 58.372 | 54.041 | 62.006 | 61.308 | 54.443 |
| Total Income - EUR | 58.228 | 58.048 | 60.945 | 59.098 | 62.444 | 58.377 | 54.046 | 62.010 | 61.340 | 54.447 |
| Total Expenses - EUR | 57.937 | 53.668 | 54.307 | 55.783 | 58.013 | 54.716 | 50.706 | 57.458 | 59.123 | 56.608 |
| Gross Profit/Loss - EUR | 291 | 4.381 | 6.638 | 3.314 | 4.431 | 3.661 | 3.340 | 4.552 | 2.217 | -2.161 |
| Net Profit/Loss - EUR | 245 | 3.679 | 5.196 | 2.724 | 3.807 | 3.108 | 2.994 | 3.932 | 1.604 | -3.757 |
| Employees | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Farmacie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 437 | 355 | 273 | 192 | 115 | 6 | 0 | 0 | 0 | 0 |
| Current Assets | 38.563 | 28.934 | 32.524 | 34.892 | 33.971 | 28.593 | 29.737 | 34.152 | 35.835 | 32.929 |
| Inventories | 17.160 | 19.646 | 19.850 | 15.892 | 17.755 | 16.991 | 16.975 | 19.682 | 22.125 | 20.832 |
| Receivables | 6.581 | 2.402 | 8.911 | 10.715 | 9.248 | 7.945 | 10.188 | 11.060 | 9.638 | 6.405 |
| Cash | 14.822 | 6.886 | 3.762 | 8.285 | 6.967 | 3.656 | 2.573 | 3.410 | 4.072 | 5.691 |
| Shareholders Funds | 13.154 | 13.020 | 17.996 | 17.666 | 17.324 | 12.088 | 11.820 | 11.857 | 11.821 | 7.998 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 25.846 | 16.268 | 14.800 | 17.418 | 16.761 | 16.511 | 17.917 | 22.295 | 24.014 | 24.931 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacie S.r.l.